Skip to main content
Jessica Ballinger

Jessica Ballinger

President & CEO, Lyndra Therapeutics
United States
Jessica Ballinger is a senior biotech and pharmaceutical executive with proven ability to identify patient needs throughout her 30+ year career. Ballinger has contributed to the development and commercialization of more than 15 leading-edge patient therapies while having a simultaneous focus on the improvement of organizational culture. Armed with a strong network, an advanced technical background, and a passion for patients, she provides innovative solutions and revitalizes operating infrastructures. As a trusted advisor and consummate leader Ballinger identifies, nurtures and coaches’ talent to achieve extraordinary results. During her time at Pfizer, Ballinger oversaw a multimillion-dollar product development budget. In the past seven years at Lyndra, she has participated in raising over ~ $260M through a combination of equity financing, partnerships, and grants, and overseen the organization of critical infrastructures that look towards commercialization.

Double Helix


Supporting Bank Sponsor


Premier Sponsors

Conference Sponsors


Media Partner


Sign up for updates

Stay up-to-date on the BIO CEO and Investor Conference via email.